Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Psychiatry

• Publication date

  2018-08-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41380-018-0208-0PMID 30108315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Electrical Stimulation Enhances Migratory Ability of Transplanted Bone Marrow Stromal Cells in a Rodent Ischemic Stroke Model

  2018cited by this paper
• Therapeutic Effect of Astroglia-like Mesenchymal Stem Cells Expressing Glutamate Transporter in a Genetic Rat Model of Depression

  2017cited by this paper
• Hippocampal neurogenesis of Wistar Kyoto rats is congenitally impaired and correlated with stress resistance

  2017cited by this paper
• Undertreatment of people with major depressive disorder in 21 countries

  2017cited by this paper
• Mesenchymal Stem Cells Preserve Working Memory in the 3xTg-AD Mouse Model of Alzheimer’s Disease

  2016cited by this paper
• MRI tracking of bone marrow mesenchymal stem cells labeled with ultra-small superparamagnetic iron oxide nanoparticles in a rat model of temporal lobe epilepsy.

  2015cited by this paper
• The forced swim test as a model of depressive-like behavior.

  2015cited by this paper
• Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets?

  2015cited by this paper
• Treatment-resistant depression: are animal models of depression fit for purpose?

  2015cited by this paper
• Increased expression of Aquaporin 4 in the rat hippocampus and cortex during trimethyltin-induced neurodegeneration.

  2014cited by this paper
• Resistance to antidepressant drugs: the case for a more predisposition-based and less hippocampocentric research paradigm

  2014cited by this paper
• Learned helplessness and social avoidance in the Wistar-Kyoto rat

  2014cited by this paper
• Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

  2013cited by this paper
• Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke

  2013cited by this paper
• The Flinders Sensitive Line Rat Model of Depression—25 Years and Still Producing

  2013cited by this paper
• The secretome of mesenchymal stem cells: potential implications for neuroregeneration.

  2013cited by this paper
• Role of Ciliary Neurotrophic Factor in the Proliferation and Differentiation of Neural Stem Cells

  2013cited by this paper
• Mesenchymal stem cells and neuroregeneration in Parkinson's disease.

  2013cited by this paper
• ndogenous ciliary neurotrophic factor modulates anxiety and depressive-like ehavior

  2012cited by this paper
• Intrahippocampal transplantation of mesenchymal stromal cells promotes neuroplasticity.

  2012cited by this paper
• BDNF-secreting capsule exerts neuroprotective effects on epilepsy model of rats.

  2011cited by this paper
• Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats.

  2011cited by this paper
• Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals

  2011cited by this paper
• Linking molecules to mood: new insight into the biology of depression.

  2010cited by this paper
• Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior

  2010influential reference
• Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on neuroprotective effects of stromal cell-derived factor-1α

  2010cited by this paper
• Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic.

  2009cited by this paper
• Vascular Endothelial Growth Factor Signaling is Required for the Behavioral Actions of Antidepressant Treatment: Pharmacological and Cellular Characterization

  2009cited by this paper
• Expression of IL-10 and TNF-α in Rats with Cerebral Infarction after Transplantation with Mesenchymal Stem Cells

  2009cited by this paper
• Putative Dental Pulp‐Derived Stem/Stromal Cells Promote Proliferation and Differentiation of Endogenous Neural Cells in the Hippocampus of Mice

  2008influential reference
• Antidepressant-like effects of intracerebroventricular FGF2 in rats.

  2008cited by this paper
• Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.

  2008cited by this paper
• The molecular neurobiology of depression

  2008cited by this paper
• Ciliary Neurotrophic Factor Mediates Dopamine D2 Receptor-Induced CNS Neurogenesis in Adult Mice

  2008cited by this paper
• Intraventricular implant of encapsulated CNTF-secreting fibroblasts ameliorates motor deficits in aged rats.

  2008cited by this paper
• VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants

  2007cited by this paper
• Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients.

  2007cited by this paper
• Lack of exercise, via hindlimb suspension, impedes endogenous neurogenesis.

  2007cited by this paper
• Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

  2006cited by this paper
• Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

  2006cited by this paper
• Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia.

  2005cited by this paper
• Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia.

  2005cited by this paper
• Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients

  2005cited by this paper
• Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity.

  2005cited by this paper
• A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis

  2005cited by this paper
• Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease

  2004cited by this paper
• Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain.

  2004cited by this paper
• Lower hippocampal volume in patients suffering from depression: a meta-analysis.

  2004cited by this paper
• Selectively bred Wistar–Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants

  2003cited by this paper
• Endogenous and exogenous ciliary neurotrophic factor enhances forebrain neurogenesis in adult mice.

  2003cited by this paper
• Strain-dependent modification of behavior following antidepressant treatment.

  2003cited by this paper
• Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons.

  2002cited by this paper
• Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

  2002cited by this paper
• Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat.

  2002cited by this paper
• Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus

  2000cited by this paper
• Diazepam induces FGF-2 mRNA in the hippocampus and striatum.

  2000cited by this paper
• Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

  2000cited by this paper
• Autoregulation of the Stat3 Gene through Cooperation with a cAMP-responsive Element-binding Protein*

  1998cited by this paper
• Strain Differences in the Behavioral Effects of Antidepressant Drugs in the Rat Forced Swimming Test

  1997cited by this paper
• Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats.

  1996cited by this paper
• Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats.

  1994cited by this paper
• [Serum concentrations of delta 5C21 steroids during pregnancy and at delivery].

  1989cited by this paper

• Non-pharmacological therapeutic paradigms in stress-induced depression: from novel therapeutic perspective with focus on cell-based strategies

  2025cites this paper
• Stem cell therapy for the treatment of psychiatric disorders: a real hope for the next decades

  2025cites this paper
• Long intervals between repetitive concussions reduce risk of cognitive impairment and limit microglial activation, astrogliosis, and tauopathy in adolescent rats

  2025cites this paper
• Molecular Reflection of the Mind: Exosomes in Major Depressive Disorder.

  2025cites this paper
• Vascular endothelial growth factor: a key factor in the onset and treatment of depression

  2025cites this paper
• The Therapeutic Potential of Stem Cells in Depression

  2025influential citation
• Clinical study of Yin-Yang balancing acupuncture plus Tuina in the treatment of post-stroke depression

  2024cites this paper
• Therapeutic Potential of Mesenchymal Stem Cells on Major Depressive Disorder

  2024cites this paper
• Investigating resistance to antidepressants in animal models.

  2024cites this paper
• An update on stem cell therapy for stroke patients: Where are we now?

  2024cites this paper
• Priming and Combined Strategies for the Application of Mesenchymal Stem Cells in Ischemic Stroke: A Promising Approach

  2024cites this paper
• Immunotherapy for depression: Recent insights and future targets.

  2024cites this paper
• Therapeutic potential and mechanisms of stem cells in major depressive disorder: a comprehensive review

  2024cites this paper
• Neurotrophic Hypothesis of the Development of Depression

  2024cites this paper
• Mesenchymal stem cells improve depressive disorder via inhibiting the inflammatory polarization of microglia.

  2024cites this paper
• Neurotrophic Hypothesis of Development of Depression

  2024cites this paper
• Patient-derived induced pluripotent stem cells: Tools to advance the understanding and drug discovery in Major Depressive Disorder.

  2024cites this paper
• Plausible Role of Stem Cell Types for Treating and Understanding the Pathophysiology of Depression

  2023cites this paper
• Dexmedetomidine alleviates host ADHD-like behaviors by reshaping the gut microbiota and reducing gut-brain inflammation.

  2023cites this paper
• Mesenchymal stromal cells alleviate depressive and anxiety-like behaviors via a lung vagal-to-brain axis in male mice

  2023cites this paper
• Potential Plausible Role of Stem Cell for Treating Depressive Disorder: a Retrospective Review

  2023cites this paper
• Transplantation of modified human bone marrow‐derived stromal cells affords therapeutic effects on cerebral ischemia in rats

  2022cites this paper
• Intricate role of sleep deprivation in modulating depression: focusing on BDNF, VEGF, serotonin, cortisol, and TNF-α

  2022cites this paper
• Differentiation of Alginate-Encapsulated Wharton Jelly-Derived Mesenchymal Stem Cells into Insulin Producing Cells

  2022cites this paper
• Human umbilical cord mesenchymal stem cells ameliorate depression by regulating Jmjd3 and microglia polarization in myocardial infarction mice

  2021cites this paper
• Neuroprotection Following Stroke

  2021cites this paper
• Meet the Editorial Board Member

  2021cites this paper
• Is there a place for cellular therapy in depression?

  2021cites this paper
• Encapsulation of Mesenchymal Stem Cells: Dissecting the Underlying Mechanism of Mesenchymal Stem Cell Transplantation Therapy

  2020cites this paper
• Protection of hUC-MSCs against Neuronal Complement C3a Receptor-mediated NLRP3 Activation in CUMS-induced Mice.

  2020cites this paper
• Intracerebroventricular Administration of hNSCs Improves Neurological Recovery after Cardiac Arrest in Rats

  2020cites this paper
• Molecular Psychiatry, August 2020: new impact factor, and highlights of recent advances in psychiatry, including an overview of the brain’s response to stress during infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

  2020cites this paper
• hUC-MSCs ameliorated CUMS-induced depression by modulating complement C3 signaling-mediated microglial polarization during astrocyte-microglia crosstalk.

  2020cites this paper
• Advances in depression research: second special issue, 2020, with highlights on biological mechanisms, clinical features, co-morbidity, genetics, imaging, and treatment

  2020cites this paper
• Cerebellar Blood Flow and Gene Expression in Crossed Cerebellar Diaschisis after Transient Middle Cerebral Artery Occlusion in Rats

  2020cites this paper
• Advances in depression research: special issue, 2020, with three research articles by Paul Greengard

  2020cites this paper
• Mesenchymal Stromal Cells Modulate Peripheral Stress-Induced Innate Immune Activation Indirectly Limiting the Emergence of Neuroinflammation-Driven Depressive and Anxiety-like Behaviors.

  2019cites this paper
• Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet?

  2019cites this paper
• Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges.

  2019cites this paper
• Lithium counteracts depressive behavior and augments the treatment effect of selective serotonin reuptake inhibitor in treatment-resistant depressed rats.

  2019cites this paper
• Cell therapy for central nervous system disorders: Current obstacles to progress

  2019cites this paper
• Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion

  2018cites this paper
• Digital Commons @ University of South Florida Digital Commons @ University of South Florida

  year unknowncites this paper